Concepedia

Danielle L Loosbrock

DL

Statistics

Publications

5

Citations

146

H-Index

5

Active since

1998

Affiliations

Eli Lilly (United States)(Current)

Danielle L Loosbrock is an author at Eli Lilly (United States) specializing in psychopharmacology, pharmacy, and antipsychotic therapy.

Publications per year

1998–2004

5

Publications

5

Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia.

Danielle L Loosbrock, Zhongyun Zhao, Bryan M. Johnstone et al. · PubMed · 2003 · 42 citations

Pharmacy, Pharmacoeconomics, Psychiatry +16

Changes in perceived health and functioning as a cost-effectiveness measure for olanzapine versus haloperidol treatment of schizophrenia.

Sandra L. Tunis, Bryan M. Johnstone, P. Joseph Gibson et al. · PubMed · 1999 · 39 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Appropriateness of Prescribing Practices for Serotonergic Antidepressants

Danielle L Loosbrock, Molly Tomlin, R.L. Robinson et al. · Psychiatric Services · 2002 · 29 citations

Pharmacy, Pharmacotherapy, Psychiatry +16

Great Expectations: The Negative Consequences of Falling Short<sup>1</sup>

Colin P. Ho, Denise Driscoll, Danielle L Loosbrock · Journal of Applied Social Psychology · 1998 · 26 citations

Social Sciences, Psychology, Social Psychology +10

Economic Outcomes Associated with Switching Individuals with Schizophrenia Between Risperidone and Olanzapine

Zhongyun Zhao, M. Namjoshi, Beth Barber et al. · CNS Drugs · 2004 · 10 citations

Pharmacy, Pharmacoeconomics, Psychiatry +13

1–5 of 5